Current position:Home >Product >
(+)-N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(2-chlorophenyl)propanamide
(+)-N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(2-chlorophenyl)propanamide(170284-18-1)
- Name: (+)-N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(2-chlorophenyl)propanamide
- Synonyms:
- Molecular Formula:
- Molecular Weight:431.922
- CAS Registry Number:170284-18-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 183558-54-5/2S-[[(N-2-methoxyethylamino)acetyl]amino]-N-[2R-hydroxy-3-[[(2-naphthyl)sulfonyl](2-methylpropyl)amino]-1S-(phenylmethyl)propyl]-3,3-dimethyl-butanamide
- 183473-96-3/(E)-3-[5-Benzyloxy-2-[2-(2-carboxyphenyl)methoxy-4-methoxy]phenylphen-1-yl]-2-[(2-methoxy-4,5-methylenedioxyphenyl)methyl]propenoic acid
- 222162-32-5/1-Benzyl-3-(5-(N-(2-naphthyl)carbamoyl)-2-furyl)indazole
- 130412-78-1/(-)-(7S,8R)-7,8-O-dibenzyloxymethoxy-2-oxo-1-azabicyclo[4.3.0]non-5-ene
- 145062-72-2/1-[4-[(2-butyl-4-chloro-5-acetoxymethyl-1H-imidazol-1-yl)methyl]phenyl]-1H-pyrrol-2-yl-carboxylic acid
- 135780-13-1/1-propyl 3-(3-phenylcarbamoyloxy propyl) 1,2-dihydro 2-oxo quinoxaline
- 145455-75-0/3-(2(R)-hydroxypropyl)amino-3-methyl-N-[2,3,4,5-tetrahydro-2-oxo-1-[[2'-(acetylaminomethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-1-benzazepin-3(R)-yl]butanamide
- 145455-37-4/3-(2(R),3-dihydroxypropyl)amino-3-methyl-N-[2,3,4,5-tetrahydro-2-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-1-benzazepin-3(R)-yl]-butanamide
- 74973-82-3/N-methylbenzamide hydrochloride
- 155685-88-4/1-(2,6-dichloro-4-trifluoromethylphenyl)-2-chloro-5-methylsulfenyl-4-chlorodifluoromethylsulfenylimidazole
- 150268-79-4/4-ureidomethyl-3-chlorophenylpropionyl aspartic acid-di-t-butyl ester
- 150597-43-6/2-[5-[(3,4-Dihydro-4-oxo-8-pentyl-2H-1-benzopyran-7-yl)oxy]pentyloxy]benzenepropanoic Acid
- 138108-48-2/N-[(S)-N-[p-[N-[(benzyloxy)carbonyl]amidino]benzoyl]-3-[(benzyloxy)carbonyl]β-alanyl]-β-alanine benzyl ester
- 1237065-55-2/3-n-butyl-1-(2-chloro-5-valerylphenyl)-4-[[3-fluoro-2'-[N-(2-fluorobenzoyl)sulfamoyl]biphenyl-4-yl]methyl]-1H-pyrazole-5-carbonitrile
- 146648-28-4/BOC-2,2-dibenzyl glycine benzyl ester
- 144313-13-3/1-[4-(4-octyloxyphenyl)benzoyl]-1H-benzotriazole-3-oxide
- 157132-82-6/2-[3-(4-Hydroxyphenoxy)propoxy]-4-(octadecyloxy) benzoic acid
- 155082-89-6/N-[4-(N,N-diethylamino)-6-mercapto-2-methoxypyrimidin-5-yl]-4-(N-hexyl-N-phenylamino)butanamide
- 141863-47-0/4-(-3-tetrahydropyranyloxy-1-propynyl)cyclohexanemethanol t-butyldimethylsilyl ether
- 170284-18-1/(+)-N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(2-chlorophenyl)propanamide
- 119318-05-7/3-[2-[4-[3-(ethyl amino)-2-pyridinyl]-1-piperazinyl]ethyl]octahydro-7-[2-(5-hydroxy-2-methylphenyl)ethyl]-3a-methyl-5H-inden-5-one
- 157373-21-2/Ethyl 8-chloro-7-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylate
- 171103-18-7/2-[2-(Nonanamido)phenoxy]benzoic acid
- 149868-16-6/1-[-6-(4-amidino phenyl)-3-pyridazinyl]-4-(2-carboxy-2-hydroxy-ethyl)-imidazole
- 158504-86-0/1-(4-morpholino)carbonyl-4-trifluoromethyl-4-hydroxy-6-(3,4-dimethoxyphenyl)cyclohex-6-en-2-one
- 151620-43-8/1-(adamantylmethyl)-2,4-dioxo-3-(3-carboxy)phenyl-oxycarbonylamino-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
- 157095-74-4/2(R)-3(S)-3-(4-fluorophenyl-ONN-azoxy)-2-butanol
- 181279-32-3/4'-(trifluoromethylsulfonyl)-3-cyano-4-(trifluoromethylsulfonyloxy)carbanilide
- 168057-22-5/N-Ethyl-4'-[[4(R)-[(2-amino-2-methyl-1-oxopropyl)-amino]-2,3,4,5-tetrahydro-3-oxo-1H-2-benzazepin-2-yl]-methyl][1,1'-biphenyl]-2-carboxamide
- 168057-81-6/3-Amino-3-methyl-N-[2,3,4,5-tetrahydro-2-[[2'-[[[(ethylamino)carbonyl]amino]methyl][1,1'-biphenyl]-4-yl]methyl]-7-methoxy-3-oxo-1H-2-benzazepin-4(R)-yl]butanamide